XML 62 R9.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Net income $ 60,512 $ 50,853 $ 47,329
Adjustments to reconcile net income to net cash used in operating activities:      
Net unrealized depreciation (appreciation) on joint ventures and other investments 4,405 (10,712) (3,219)
Net gain on loans accounted for under the fair value option (61,157) (5,200) (18,008)
Net gain on residuals in securitizations (30,015) 0 0
Net loss on loan servicing assets 16,692 12,665 4,282
Net unrealized (appreciation) depreciation on warrants and derivative transactions (74) (1,344) 699
Unrealized loss on assets classified as held for sale 0 616 0
Net gain on sales of loans (47,555) (97,183) (51,467)
Net accretion of premium/discount on debt securities available-for-sale and loans (1,319) (836) (675)
Loss on extinguishment of debt, deferred financing costs expensed 158 0 271
Amortization of deferred financing costs and deferred loan fees and costs 4,396 4,564 4,052
Provision for credit losses 38,729 26,216 11,704
Lower of cost or market adjustment on loans held for sale (12) (73) 0
Bad debt expense, net of recoveries 283 1,059 3,637
Stock compensation expense 4,097 4,062 2,828
Deferred income tax expense (benefit) 8,482 10,403 (4,800)
Depreciation and amortization 668 1,784 2,884
Proceeds from sale of loans held for sale 404,547 817,869 695,461
Sale of loans held for sale from affiliate 0 140,009 (5,279)
Funding of loans held for sale (1,062,896) (1,125,131) (783,035)
Principal received on loans held for sale 23,128 18,898 12,235
Other, net (1,249) 0 0
Changes in operating assets and liabilities:      
Settlement receivable 52,027 9,765 (62,230)
Dividends receivable 0 0 493
Other assets (21,104) (13,660) 7,432
Assets classified as held for sale 0 (1,497) 0
Liabilities directly associated with assets classified as held for sale 0 (174) 0
Dividends payable 0 441 4,776
Due to participants 30,857 (2,264) (11,832)
Accounts payable, accrued expenses and other liabilities (2,841) 6,086 (26,757)
Net cash used in operating activities (579,241) (153,014) (169,219)
Cash flows from investing activities:      
Principal received on loans held for investment, at fair value 71,830 71,576 39,601
Repurchases of loans held for investment, at fair value (4,669) (4,759) (10,252)
Net increase in loans held for investment, at cost (313,270) (278,539) (169,003)
Proceeds from sale of Newtek Technology Solutions, Inc. 4,000 0 0
Asset purchase of controlling interest in NCL JV, net of cash acquired (10,120) 0 0
Contributions to joint ventures and other investments (85) (25,680) (14,550)
Return of capital from joint ventures and other investments 14 20,301 564
Purchase of fixed assets (106) (439) (458)
Sales of Federal Home Loan Bank and Federal Reserve Bank stock 361 1,071 1,330
Purchases of Federal Home Loan Bank and Federal Reserve Bank stock (1,010) (1,021) (3,442)
Purchases of available-for-sale securities (19,937) (33,021) (28,668)
Maturities of available-for-sale securities 27,700 41,460 1,501
Acquisitions, net of cash acquired 0 0 11,142
Net cash used in investing activities (245,292) (209,051) (172,235)
Cash flows from financing activities:      
Borrowing on bank notes payable 531,200 277,240 249,017
Repayment on bank notes payable (353,803) (205,627) (327,680)
Net increase in deposits 444,352 508,577 324,705
Repayment of Federal Home Loan Bank advances (8,026) (7,959) (4,895)
Proceeds from common shares sold, net of offering costs 5,091 13,818 0
Proceeds from preferred stock, net of offering costs 48,181 0 19,493
Securities purchase and exchange agreement 10,000 0 0
Repurchase of common shares under share repurchase plan (1,491) 0 0
Payments on Notes Payable - Securitization Trusts (60,404) (106,992) (90,780)
Proceeds related to residuals in securitizations 169,420   103,860
Dividends paid, net of dividend reinvestment plan (28,044) (20,252) (14,147)
Payments of deferred financing costs (3,056) (6,039) (4,650)
Proceeds from common stock issued under ESPP, net of discount 268 207 51
Purchase of vested stock for employee payroll tax withholding (2,171) (299) 0
Retirement of common shares 0 (402) 0
Net cash provided by financing activities 753,450 560,897 344,974
Net (decrease) increase in cash and restricted cash (71,083) 198,832 3,520
Cash and restricted cash—beginning of period (NOTE 2) 381,374 184,006 125,606
Consolidation/(deconsolidation) of cash and restricted cash from controlled investments related to business combinations and dispositions, net of cash paid 0 (1,464) 54,880
Cash and restricted cash—end of period (NOTE 2) 310,291 381,374 184,006
Non-cash operating, investing and financing activities:      
Foreclosed real estate acquired 11,423 4,569 2,978
Dividends declared but not paid during the period 0 5,237 4,363
Loans and accrued interest acquired through asset acquisition 26,213 0 0
Securities purchase and exchange agreement conversion 19,738 0 0
Issuance of common shares under dividend reinvestment plan 0 0 219
Supplemental disclosure of cash flow information:      
Interest paid 97,479 79,192 66,471
Income taxes paid 12,502 7,429 6,884
Other Investments      
Adjustments to reconcile net income to net cash used in operating activities:      
Net unrealized depreciation (appreciation) on joint ventures and other investments 763 (128)  
Principal received on investments 0 (230) 0
Stock Acquired      
Non-cash operating, investing and financing activities:      
IPM 8,200 0 0
Earn Out Receivable      
Non-cash operating, investing and financing activities:      
IPM 2,268 0 0
2025 8.13% Notes      
Cash flows from financing activities:      
Proceeds from Notes 0 0 50,000
8.00% Notes due 2028      
Cash flows from financing activities:      
Proceeds from Notes 0 0 40,000
2024 Notes      
Cash flows from financing activities:      
Redemption of Notes 0 (38,250) 0
2025 5.00% Notes      
Cash flows from financing activities:      
Redemption of Notes (30,000) 0 0
2029 8.50% Notes      
Cash flows from financing activities:      
Proceeds from Notes 0 71,875 0
Purchase of 2029 8.50% Notes (67) 0 0
2029 8.625% Notes      
Cash flows from financing activities:      
Proceeds from Notes 0 75,000 0
2030 8.375% Notes      
Cash flows from financing activities:      
Proceeds from Notes $ 32,000 $ 0 $ 0